Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity
The present invention concerns methods and compositions for forming immunotoxin complexes having a high efficacy and low systemic toxicity. In preferred embodiments, the toxin moiety is a ranpirnase (Rap), such as Rap(Q). In more preferred embodiments, the immunotoxin is made using dock-and-lock (DNL) technology. The immunotoxin exhibits improved pharmacokinetics, with a longer serum half-life and significantly greater efficacy compared to toxin alone, antibody alone, unconjugated toxin plus antibody or even other types of toxin-antibody constructs. In a most preferred embodiment the construct comprises an anti-Trop-2 antibody conjugated to Rap, although other combinations of antibodies, antibody fragments and toxins may be used to form the subject immunotoxins. The immunotoxins are of use to treat a variety of diseases, such as cancer, autoimmune disease or immune dysfunction.
IBC Pharmaceuticals, Inc. Immunomedics, Inc.
A A A C A A A A A A C C A A A A A A A A A A A C A C C A C A A A A C B A C C C A A C A
A61P A61K A61K C07K A61K A61K A61P A61K A61P A61P C07K C07K A61P A61P A61K A61P A61P A61P A61P A61K A61P A61K A61P C07K A61K C07K C07K A61P C07K A61K A61P A61P A61P C07K B82Y A61K C07K C07K C12N A61K A61P C07K A61P
inventional inventional inventional inventional inventional inventional inventional additional inventional inventional additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional additional inventional inventional additional additional inventional additional inventional additional inventional
David M. Edmund A. Chien-Hsing
Goldenberg Rossi Chang